» Articles » PMID: 2472218

EGF Induces Tyrosine Phosphorylation of Phospholipase C-II: a Potential Mechanism for EGF Receptor Signaling

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1989 Jun 30
PMID 2472218
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Binding of EGF to cells expressing human EGF receptor stimulated rapid tyrosine phosphorylation of phospholipase C-II (PLC-II), as revealed by immunoblotting analysis with phosphotyrosine-specific antibodies. Tyrosine phosphorylation of PLC-II was stimulated by low physiological concentrations of EGF (1 nM), was quantitative, and was already maximal after a 30 sec incubation with 50 nM EGF at 37 degrees C. Interestingly, antibodies specific for PLC-II were able to coimmunoprecipitate the EGF receptor and antibodies against EGF receptor also coimmunoprecipitated PLC-II. According to this analysis, approximately 1% of EGF receptor molecules were associated with PLC-II molecules. The protein tyrosine kinase inhibitor tyrphostin RG50864, which blocks EGF-dependent cell proliferation, blocked EGF-induced tyrosine phosphorylation of PLC-II, its association with EGF receptor, and EGF-induced Ca2+ release. Hence, EGF-induced tyrosine phosphorylation of PLC-II may be a regulatory event linking the tyrosine kinase activity of EGF receptor to the PIP2 hydrolysis signaling pathway.

Citing Articles

Cryptic mutations of PLC family members in brain disorders: recent discoveries and a deep-learning-based approach.

Lim K, Yang S, Kim S, Ko E, Kang M, Joo J Brain. 2022; 146(4):1267-1280.

PMID: 36448305 PMC: 10115239. DOI: 10.1093/brain/awac451.


EGFR Signaling in Lung Fibrosis.

Schramm F, Schaefer L, Wygrecka M Cells. 2022; 11(6).

PMID: 35326439 PMC: 8947373. DOI: 10.3390/cells11060986.


Comprehensive review of targeted therapy for colorectal cancer.

Xie Y, Chen Y, Fang J Signal Transduct Target Ther. 2020; 5(1):22.

PMID: 32296018 PMC: 7082344. DOI: 10.1038/s41392-020-0116-z.


EGF Receptor Stalls upon Activation as Evidenced by Complementary Fluorescence Correlation Spectroscopy and Fluorescence Recovery after Photobleaching Measurements.

Vamosi G, Friedlander-Brock E, Ibrahim S, Brock R, Szollosi J, Vereb G Int J Mol Sci. 2019; 20(13).

PMID: 31323980 PMC: 6650801. DOI: 10.3390/ijms20133370.


Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications.

Quintanal-Villalonga A, Paz-Ares L, Ferrer I, Molina-Pinelo S Dis Markers. 2016; 2016:9214056.

PMID: 27528792 PMC: 4977389. DOI: 10.1155/2016/9214056.